dr. toni choueiri on cabozantinib versus everolimus in renal cell carcinoma
Published 8 years ago • 417 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
5:42
meteor trial: cabozantinib vs everolimus in advanced renal cell carcinoma
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
0:52
dr. choueiri on impact of cabosun results in renal cell carcinoma
-
1:06
dr. choueiri on fda approval of cabozantinib for rcc
-
1:44
dr. choueiri on cabosun trial results in rcc
-
1:06
dr. toni choueiri on nivolumab and cabozantinib becoming first-line therapies in rcc
-
1:45
dr. choueiri on cabosun trial results for rcc
-
7:34
frontline sunitinib compared to everolimus in metastatic renal cell carcinoma
-
2:16
highlights in renal cell carcinoma - dr. toni choueiri
-
6:31
toni choueiri:
-
1:38
kidney cancer research at esmo 2020: toni choueiri, md
-
1:14
dr. choueiri on significance of checkmate-025 study for rcc
-
5:19
lenvatinib and cabozantinib in renal cell carcinoma
-
1:20
dr. choueiri on overall findings of cabosun trial for rcc
-
5:08
cabosun trial of upfront cabozantinib in metastatic rcc
-
1:08
dr. choueiri on the biology of the cabosun trial for rcc